These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 36939932)

  • 1. COVID-19 severity is related to poor executive function in people with post-COVID conditions.
    Ariza M; Cano N; Segura B; Adan A; Bargalló N; Caldú X; Campabadal A; Jurado MA; Mataró M; Pueyo R; Sala-Llonch R; Barrué C; Bejar J; Cortés CU; ; Garolera M; Junqué C
    J Neurol; 2023 May; 270(5):2392-2408. PubMed ID: 36939932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints.
    Ariza M; Cano N; Segura B; Adan A; Bargalló N; Caldú X; Campabadal A; Jurado MA; Mataró M; Pueyo R; Sala-Llonch R; Barrué C; Bejar J; Cortés CU; ; Junqué C; Garolera M
    Front Aging Neurosci; 2022; 14():1029842. PubMed ID: 36337708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cognitive functions in adult individuals with COVID-19.
    Akıncı B; Oğul ÖE; Hanoğlu L; Kulaç B; Ören D; Ulu O; Basançelebi B
    Neurol Sci; 2023 Mar; 44(3):793-802. PubMed ID: 36574178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: Cognitive functioning.
    Whiteside DM; Basso MR; Naini SM; Porter J; Holker E; Waldron EJ; Melnik TE; Niskanen N; Taylor SE
    Clin Neuropsychol; 2022 May; 36(4):806-828. PubMed ID: 35130818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What do we mean by long COVID? A scoping review of the cognitive sequelae of SARS-CoV-2 infection.
    Nicotra A; Masserini F; Calcaterra F; Di Vito C; Doneddu PE; Pomati S; Nobile-Orazio E; Riva A; Mavilio D; Pantoni L
    Eur J Neurol; 2023 Dec; 30(12):3968-3978. PubMed ID: 37540896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of objective and subjective cognitive function in Post-COVID Syndrome, COVID-19 recovered, and COVID-19 naïve individuals.
    Bland AR; Barraclough M; Trender WR; Mehta MA; Hellyer PJ; Hampshire A; Penner IK; Elliott R; Harenwall S
    Sci Rep; 2024 Jun; 14(1):13368. PubMed ID: 38862569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid improvement in severe long COVID following perispinal etanercept.
    Tobinick E; Spengler RN; Ignatowski TA; Wassel M; Laborde S
    Curr Med Res Opin; 2022 Dec; 38(12):2013-2020. PubMed ID: 35791687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological manifestations of long COVID in hospitalized and non-hospitalized Brazilian Patients.
    Braga LW; Oliveira SB; Moreira AS; Pereira ME; Carneiro VS; Serio AS; Freitas LF; Isidro HBL; Souza LMN
    NeuroRehabilitation; 2022; 50(4):391-400. PubMed ID: 35599507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort.
    Schild AK; Goereci Y; Scharfenberg D; Klein K; Lülling J; Meiberth D; Schweitzer F; Stürmer S; Zeyen P; Sahin D; Fink GR; Jessen F; Franke C; Onur OA; Kessler J; Warnke C; Maier F
    J Neurol; 2023 Mar; 270(3):1215-1223. PubMed ID: 36422669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence and emergence of new neuropsychological deficits following SARS-CoV-2 infection: A follow-up assessment of the Geneva COVID-COG cohort.
    Voruz P; de Alcântara IJ; Nuber-Champier A; Cionca A; Guérin D; Allali G; Benzakour L; Lalive PH; Lövblad KO; Braillard O; Nencha U; Nehme M; Coen M; Serratrice J; Reny JL; Pugin J; Guessous I; Landis BN; Assal F; Péron JA
    J Glob Health; 2024 Mar; 14():05008. PubMed ID: 38452292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological deficits in patients with cognitive complaints after COVID-19.
    García-Sánchez C; Calabria M; Grunden N; Pons C; Arroyo JA; Gómez-Anson B; Lleó A; Alcolea D; Belvís R; Morollón N; Mur I; Pomar V; Domingo P
    Brain Behav; 2022 Mar; 12(3):e2508. PubMed ID: 35137561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognition and Memory after Covid-19 in a Large Community Sample.
    Hampshire A; Azor A; Atchison C; Trender W; Hellyer PJ; Giunchiglia V; Husain M; Cooke GS; Cooper E; Lound A; Donnelly CA; Chadeau-Hyam M; Ward H; Elliott P
    N Engl J Med; 2024 Feb; 390(9):806-818. PubMed ID: 38416429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of computerized cognitive rehabilitation in improving attention and executive functions in acquired brain injury patients, in acute and postacute phase.
    Kim HS; Lim KB; Yoo J; Kim YW; Lee SW; Son S; Kim C; Kim J
    Eur J Phys Rehabil Med; 2021 Aug; 57(4):551-559. PubMed ID: 33448753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID Syndrome.
    Dressing A; Bormann T; Blazhenets G; Schroeter N; Walter LI; Thurow J; August D; Hilger H; Stete K; Gerstacker K; Arndt S; Rau A; Urbach H; Rieg S; Wagner D; Weiller C; Meyer PT; Hosp JA
    J Nucl Med; 2022 Jul; 63(7):1058-1063. PubMed ID: 34649946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive Profiles in Patients With Persisting Cognitive Symptoms Associated With COVID-19.
    Krishnan K; Miller AK; Reiter K; Bonner-Jackson A
    Arch Clin Neuropsychol; 2022 May; 37(4):729-737. PubMed ID: 35136912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19 infection on cognition and its association with neurological symptoms.
    Almeria M; Cejudo JC; Sanz-Santos J; Deus J; Krupinski J
    Brain Behav; 2023 Apr; 13(4):e2902. PubMed ID: 36811291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms.
    Calabria M; García-Sánchez C; Grunden N; Pons C; Arroyo JA; Gómez-Anson B; Estévez García MDC; Belvís R; Morollón N; Vera Igual J; Mur I; Pomar V; Domingo P
    J Neurol; 2022 Aug; 269(8):3990-3999. PubMed ID: 35488918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive Complaints Assessment and Neuropsychiatric Disorders After Mild COVID-19 Infection.
    Hammerle MB; Sales DS; Pinheiro PG; Gouvea EG; de Almeida PIFM; de Araujo Davico C; Souza RS; Spedo CT; Nicaretta DH; Alvarenga RMP; Pires KL; Thuler LCS; Vasconcelos CCF
    Arch Clin Neuropsychol; 2023 Feb; 38(2):196-204. PubMed ID: 36464245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.